During Urjit Patel's tenure as governor, RBI had run-ins with the government on numerous issues
Nuveen offers a comprehensive range of outcome-focused investment solutions designed to secure the long-term financial goals of institutional and individual investors
The counting of votes in Telangana and in the other four states that went to polls will take place on Tuesday
There was overall growth across all product segments such as health insurance, personal accident and travel, and commercial products and crop insurance
Top bank CEOs in a panel discussion at the Business Standard Annual Banking Forum 2018
Top experts discuss the way ahead for NBFCs in BS Round Table
Experts agreed that banks cannot avoid disruption but can leverage reach, technology and economies of scale of new-age players
Chola MS offers a wide range of insurance products across motor and non-motor lines of business through IndusInd Bank's outlets across India
Liraglutide has become a bio-generic in the markets where Novo Nordisk's patent has expired
A 25 per cent instalment was paid last month
Motorcycle sales have seen a growth of 20% to 150,429 units, from 125,409 units in Oct 2017
Profit on sale of investments grew substantially to Rs 10 billion in Q2 FY2019, whereas during Q2 FY2018 it stood at Rs 630 million
Deep Raj Saxena, CEO Middle East & Africa Cluster, VA Tech Wabag, said the order was a major breakthrough for the company in Saudi Arabia
Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion
Net profit stood at Rs 2.68 billion compared to Rs 4.53 billion in the year-ago period
The acquisition will enable NIIF to provide private debt funding to infrastructure projects
80% of the new employment requirements over the next decade would arise in the 10 states
However, drug firms focussed on domestic market would post muted growth in Q2FY19 on a year-on-year basis
AnyTimeLoan.in has a minimum net owned fund of Rs 20 million
Therapiva Private Limited is a joint venture between Omnicare Drugs India Private Limited, a subsidiary of Neopharma LLC, Abu Dhabi and Laxai Life Sciences Private Limited